Compare McKesson Corporation (MCK) vs NOV Inc. Common Stock (NOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs NOV Inc. Common Stock — how do they compare? McKesson Corporation trades at $941.12 (market cap $108.46B), while NOV Inc. Common Stock trades at $18.96 (market cap $6.77B). The key difference: McKesson Corporation is far larger — about 16× NOV Inc. Common Stock's market cap, and NOV Inc. Common Stock pays the higher dividend (1.9%). Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and NOV Inc. Common Stock for 1 Days on average.
| MCK | NOV | |
|---|---|---|
Market Cap | $108.46B | $6.77B |
Volume | 712,607 | 3,592,724 |
Sector | Health | Energy |
52-Week High | $995.69 | $21.71 |
52-Week Low | $725.17 | $12.31 |
Typical Hold Time | 74 Days | 1 Days |
Enterprise Value | $115.00B | $7.93B |
Dividend Yield | 0.4% | 1.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $937.98, up 3.04% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q2 2026 EPS of $9.93 exceeding expectations of $9.56. Recent positive developments include the CVS Health partnership extension through 2032 and raised full-year guidance. Revenue growth remains robust at $359.05 billion for 2025, though net margins are thin at 1.12%.
The outlook remains positive with 81% analyst buy ratings and a $956.43 consensus target. Key risks include margin pressure from drug pricing dynamics and policy uncertainty. Strong cash flow generation ($6.09B operating cash flow) supports the dividend and growth initiatives, while technical indicators show the stock testing resistance near $938.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About NOV Inc. Common Stock
NOV provides technology, equipment, and services for energy production. Its offerings support drilling, well construction, and production across oil, gas, renewables, and emerging energy markets.
Read more on NOV →
